Shows
The Healthcare StageThe Healthcare Stage I Episode 12 I Accellta's Journey: Innovating Stem Cells for FoodTechIn this episode, we explore the journey of Accellta, an Israeli company founded 12 years ago with a mission to revolutionize the cultivation and manufacturing of stem cells. Stem cells, known for their ability to differentiate into various specialized cell types and undergo unlimited cell divisions, hold immense potential in the biotech and food-tech industries.
Accellta's proprietary 3D suspension culture platform addresses the critical scalability bottleneck in stem cell production, enabling large-scale, cost-effective manufacturing. Their innovative approach ensures affordable end-products, including chemically defined media and proprietary stable cell lines derived from humans, aquatic animals, and farm animals.
2024-07-0328 minThe Healthcare StageThe Healthcare Stage I Episode 11 I MDI's Novel Solution for Optimizing Health Outcomes & Reducing Costs in Polypharmacy PatientsIn this episode, we sit down with Avishai Ben Tovim, CEO of MDI, a company founded in 2019. MDI has developed a groundbreaking risk analysis system for polypharmacy patients, designed to manage complex cases and provide accurate clinical recommendations for treatment optimization and risk mitigation.
Despite increasing efforts to prevent adverse drug reactions over the past decade, drug-induced hospitalizations and mortality rates continue to rise. MDI's medication management platform addresses this issue by scaling up the prevention process, helping physicians and payors avoid the clinical and financial consequences of drug-related adverse events.
The platform conducts comprehensive...
2024-07-021h 41The Healthcare StageThe Healthcare Stage I Episode 10 I A novel navigation system for ERCP procedure by Swift DuctIn this episode, we delve into the groundbreaking innovations of Swift Duct, an Israeli medical device company founded in 2020, with CEO Samer Abboud. Swift Duct is on a mission to transform Endoscopic retrograde cholangio-pancreatography (ERCP), a vital procedure aimed at and treating detecting biliary and pancreatic duct blockages.
Through a captivating discussion, we discuss how Swift Duct's cutting-edge navigation solution aims to revolutionize ERCP, promising easier, faster, and safer procedures. With a catheter boasting unique bending capabilities and a sensor-equipped guidewire, the company aims to streamline the process, reduce trial and error, and ultimately mitigate healthcare costs...
2024-05-1929 minThe Healthcare StageThe Healthcare Stage I Episode 9 I Pulsar Medtech's breakthrough bone growth stimulation device for fresh fractures treatment.In this episode, we delve into a fascinating conversation with Elad Yakobson, the CEO of Pulsar Medtech, an Israeli startup making waves in the MedTech industry. Tune in to discover how Pulsar Medtech is revolutionizing bone healing with its innovative Bone Growth Stimulation devices.
Pulsar Medtech's devices offer a promising solution to enhance patient comfort and compliance, addressing challenges commonly faced with existing bone growth stimulation devices. With lightweight patches designed for improved comfort and adherence, Pulsar Medtech is paving the way for better clinical outcomes.
Discover the safety and efficacy of Pulsar Medtech's devices...
2024-05-1940 minThe Healthcare StageThe Healthcare Stage I Episode 8 I Golden Heart Flower's GHF201: Advancing Rare Disease TreatmentThis episode is dedicated to a conversation with Yaniv Glazer, The CEO of Golden Heart Flower, an early-stage Israeli pharmaceutical company dedicated to addressing rare diseases. Specifically, we explore their focus on Adult Polyglucosan Body Disease (APBD) and their development of GHF201, a small molecule drug. GHF201 shows promise beyond APBD, potentially impacting various lysosomal storage diseases by enhancing lysosomal activity.
With approval for compassionate use from the Israeli Ministry of Health, the company has gathered 5 years of clinical data from 3 APBD patients, indicating both safety and efficacy.
Currently seeking $10M in funding to complete...
2024-04-0436 minThe Healthcare StageRevolutionizing Colonoscopy: Introducing VTM TechnologiesThis episode is dedicated to a conversation with Avishay Sidlesky, The CEO of VTM technologies, an Israeli medical device startup.
In the battle against colorectal cancer (CRC), VTM Technologies developed an innovative laser-based Virtual Tape-Measure. This new tool provides an assessment of polyp size during colonoscopy procedures, offering unparalleled accuracy and objectivity. With FDA approval already secured, VTM Technologies wishes to transform the landscape of CRC screening and surveillance.
Colonoscopy, a cornerstone of CRC prevention, holds significant importance in detecting and monitoring the disease, which ranks as the second leading cause of cancer death globally...
2024-03-2126 minThe Healthcare StageThe Healthcare Stage I Episode 6 I Applying precision oncology to study the effect of anesthetic and analgesic drug on cancer outcomesIn this episode, we're zeroing in on how precision oncology principles are revolutionizing our understanding of anesthetic and analgesic drugs and their potential influence on cancer outcomes. My guest, Professor Joshua Mincer from the Memorial Sloan Kettering Cancer Center in New York, unveils cutting-edge research applying these principles to gauge the effects of anesthetics and painkillers on cancer patient outcomes, viewed through the prism of patient-specific omics data. This line of research is particularly important since most anesthetic and anti-pain medications are generic drugs, hinting at the possibility of boosting patient outcomes without the burden of extra costs. Moreover...
2024-02-2825 minThe Healthcare StageThe Healthcare Stage I Episode 5 I ClearCut’s novel device for margin assessment of tissue excised during lumpectomyThis episode is dedicated to ClearCut medical, a commercial-stage medical device company based in Israel. The company developed the @ClearCoast™ system, a novel portable @MRI scanner for real-time intra-operative margin assessment of excised tissue during Breast Conserving Surgery (BCS), also known as lumpectomy.
With the ClearCoast™ @MRI system the surgeon can instantly identify, while at the operating room, marginal areas suspected to be malignant without special training for interpretation. As a result, there is no need to wait for pathologist assessment, and the surgeon can immediately proceed to remove the remaining malignant tissue at the margins without wait...
2024-02-1948 minThe Healthcare StageThe Healthcare Stage I Episode 4 I A Dairy-Derived Solution developed by Exosomm for IBD Relief.This episode is dedicated to an Israeli food-tech startup named Exosomm, established in 2021. The company’s first product is a proprietary formula for Inflammatory Bowel Diseases (IBD), containing milk exosomes derived from cow milk.
The scientific basis for this company originates from many years of research conducted at Hadassah Medical Center, which generated robust evidence demonstrating the anti-inflammatory activity of mammals’ milk-derived exosomes. These findings were shown in multiple preclinical studies in both IBD models but also in additional indications.
Their first product, regulated as food, is intended for use in ulcerative colitis and Crohn’s pati...
2024-02-1338 minThe Healthcare StageThe Healthcare Stage I Episode 3 I Insights from the COMEET Study with Dr. Idit Lachover RothThis Episode is dedicated to a conversation with Dr. Idit Lachover-Roth, the principal investigator of the COMEET study- a prospective clinical study conducted in Israel in more than 2000 infants. The primary focus of this study was to explore if early exposure to cow's milk formula (CMF) influences the likelihood of developing IgE-mediated cow's milk allergy (CMA) in infants. The results were revealing: infants who consistently consumed CMF from birth showed a significantly reduced incidence of IgE-mediated CMA compared to those who had only occasional CMF exposure. These findings underscore the importance of both the timing and regularity of CMF...
2024-01-2829 minThe Healthcare StageThe Healthcare Stage I Episode 2 I Unveiling the Brain's Secrets: A Conversation with Dr. Abigail Livny Ezer on the Future of NeuroimagingIn this episode, we dive into the exceptional work conducted at Dr. Abigail Livny Ezer's neuroimaging laboratory, located within Sheba Medical Center. This distinctive lab specializes in producing patient-specific structural and functional brain maps. These maps are crucial in investigating the operation and malfunctions of neuronal networks in various neuropathologies.
In recent years, Dr. Livny Ezer's team has been at the forefront of crafting new algorithms derived from these brain maps. The applications of these groundbreaking algorithms are diverse and impactful. Firstly, they provide crucial assistance to neurosurgeons during intricate brain surgeries. Secondly, they serve as a...
2024-01-2222 minThe Healthcare StageThe Healthcare stage I Episode 1 I The next generation of powered muscle stimulator developed by NeuroTriggerThis episode delves into the innovative world of NeuroTrigger, an Israeli medical device startup revolutionizing the treatment of facial paralysis.
In this episode, Im thrilled to welcome Dr. Nikolai Kunicher, CEO of NeuroTrigger, for an in-depth conversation exploring how their cutting-edge, Bluetooth-controlled device is re-educating facial muscles in an aesthetic and user-friendly manner.
Join us as we uncover the stories of patients whose lives are being transformed by this technology. 🚀 Plus, get a sneak peek into NeuroTrigger ambitious plans for a large-scale clinical study spanning the US, Israel, and the UK. For NeuroTrigger, this is a y...
2024-01-0123 min